Press release
Global Prenatal And New-born Genetic Testing Market Is Projected To Surge Ahead At A CAGR Of 16.6 % From 2023 To 2032 - Exclusive Report By GIS
Request for Free Sample @ https://www.globalinsightservices.com/request-sample/GIS10516/?utm_source=SnehaPatil&utm_medium=Openpr&utm_campaign=06122023
These tests not only aid in risk assessment but also empower informed decision-making for expectant parents and facilitate early interventions, fostering improved clinical outcomes and personalized healthcare strategies for newborns. The continuous innovation in genetic testing methods, coupled with growing awareness and acceptance, positions the prenatal and newborn genetic testing market at the forefront of improving neonatal care and family planning.
Key Trends
An influential trend shaping the prenatal and newborn genetic testing market is the rapid integration of non-invasive prenatal testing (NIPT) and expanded genetic screening options. NIPT, leveraging cell-free fetal DNA from maternal blood, has gained immense traction due to its high accuracy in detecting chromosomal abnormalities like Down syndrome, without posing risks to the fetus. Moreover, the expanding spectrum of genetic screening panels now encompasses a wider range of genetic conditions, allowing for comprehensive assessment of potential risks early in pregnancy or at birth. This trend reflects a paradigm shift towards more extensive and accurate testing options, empowering parents with valuable genetic information and aiding healthcare providers in delivering tailored interventions and counseling, ultimately contributing to improved perinatal care and better health outcomes for newborns.
Read Full Research Report @ https://www.globalinsightservices.com/reports/prenatal-and-newborn-genetic-testing-market/?utm_source=SnehaPatil&utm_medium=Openpr&utm_campaign=06122023
Key Drivers
A primary driver fueling the growth of the prenatal and newborn genetic testing market is the increasing awareness and adoption of precision medicine in reproductive and pediatric healthcare. The growing understanding of genetic factors influencing health and disease susceptibility in newborns, coupled with technological advancements, has propelled the demand for genetic testing during pregnancy and after birth. This trend is further augmented by the rising focus on personalized healthcare, wherein genetic testing provides valuable insights into potential risks of hereditary diseases and developmental disorders. Consequently, expectant parents and healthcare professionals are increasingly embracing genetic testing to assess risks, make informed decisions regarding pregnancies, and enable early interventions, underscoring the pivotal role of genetics in shaping individualized care strategies for both prenatal and newborn stages.
Buy Now@ https://www.globalinsightservices.com/checkout/single_user/GIS10516/?utm_source=SnehaPatil&utm_medium=Openpr&utm_campaign=06122023
Market Segmentation : Prenatal and New-born Genetic Testing Market
Prenatal and New-born Genetic Testing Market By Technology : Screening, Diagnostics
Prenatal and New-born Genetic Testing Market By Disease : Downs Syndrome, Cystic Fibrosis, Sickle Cell Anemia, Others
Prenatal and New-born Genetic Testing Market By End-use : Hospitals, Maternity & Specialty Clinics, Diagnostic Centers
Prenatal and New-born Genetic Testing Market By Region : North America : US, Canada, Mexico, Europe : The UK, Germany, France, Italy, Spain, Netherlands, Switzerland, Asia-Pacific : China, India, Japan, South Korea, Australia, Singapore, Indonesia, Rest of Asia-Pacific, Rest of the World : Latin America, Middle East, Africa
Key Players :
Ariosa Diagnostics (Roche)
Berry Genomics
BGI
Biorad
Illumina
Laboratory Corporation of America
Natera
Qiagen
Sequenom
Trivitron Healthcare
Verinata Health
Request for Customization @ https://www.globalinsightservices.com/request-customization/GIS10516/?utm_source=SnehaPatil&utm_medium=Openpr&utm_campaign=06122023
With Global Insight Services, you receive :
10-year forecast to help you make strategic decisions
In-depth segmentation which can be customized as per your requirements
Free consultation with lead analyst of the report
Excel data pack included with all report purchases
Robust and transparent research methodology
Contact Us :
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 15998
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services :
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Prenatal And New-born Genetic Testing Market Is Projected To Surge Ahead At A CAGR Of 16.6 % From 2023 To 2032 - Exclusive Report By GIS here
News-ID: 3317293 • Views: …
More Releases from Global Insight Services
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved…
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the…
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview
Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger…
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview
Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire…
More Releases for Prenatal
Non-Invasive Prenatal Testing (NIPT) Market Set to Transform Prenatal Care World …
Market Overview
The global non-invasive prenatal testing NIPT market reached US$ 6.31 billion in 2023 and increased to US$ 7.35 billion in 2024. It is projected to reach US$ 22.41 billion by 2033, growing at a compound annual growth rate CAGR of 13.2% during the forecast period 2025-2033. The market is driven by the rising prevalence of chromosomal abnormalities, increasing maternal age, and growing demand for safe, non-invasive screening methods. NIPT…
Unlocking the Future of Prenatal Care: Insights into the Australia Non-Invasive …
Australia's NIPT market is growing as more parents choose safe, early screening for chromosomal abnormalities. Driven by rising maternal age, advanced sequencing technology, and increasing awareness, NIPT offers high accuracy without invasive procedures. As labs expand test panels and policymakers consider broader reimbursement, NIPT is reshaping prenatal care, making comprehensive and reliable insights accessible to expecting families across Australia.
The Australian non-invasive prenatal testing (NIPT) market is undergoing remarkable growth, transforming…
Revolutionizing Prenatal Care: Insights into the Growing Non-Invasive Prenatal T …
Mordor Intelligence has published a new report on the Non-invasive Prenatal Testing Market, offering a comprehensive analysis of trends, growth drivers, and future projections.
The global non-invasive prenatal testing (NIPT) market is projected to expand significantly, with expectations to grow from USD 3.90 billion in 2025 to USD 7.35 billion by 2030, reflecting a compound annual growth rate (CAGR) of 13.5%. This growth is primarily attributed to…
Prenatal Diagnostics Market Companies Overview 2019 - 2027
Global Prenatal Diagnostics Market: Overview
Prenatal diagnostics is a procedure for testing the fetus before birth to determine certain hereditary disorders such as Down's syndrome, genetic diseases, chromosome abnormalities, neural tube defects, and other conditions. In case of high risk related to the birth of a child, it can assist by conducting numerous procedures of genetic testing common testing, and screening.
Report Overview @ https://www.transparencymarketresearch.com/prenatal-diagnostics-market.html
The global prenatal diagnostics market is segmented on…
Non-Invasive Prenatal Testing Market : Lucrative Opportunities
Non-Invasive Prenatal Testing Market: Introduction
Transparency Market Research has published a new report titled 'Global Non-Invasive Prenatal Testing Market'. According to the report, the global non-invasive prenatal testing market was valued at approximately US$ 1.3 Bn in 2018. The global non-invasive prenatal testing market is expected to expand at a CAGR of 16.4% during the forecast period from 2019 to 2027.
Overview
Rise in prevalence of chronic conditions, such as cancer and diabetes,…
Prenatal Vitamin Supplements Market: Rising Incidence of Prenatal Defects to Fue …
Global Prenatal Vitamin Supplements Market: Overview
Prenatal vitamins are the mineral and vitamin supplements used by during their pregnancy for the healthy development of the fetus. Prenatal vitamins are also recommended by doctors before conception and post conception lactation period. These vitamins are like other common man multivitamins but with different concentration of vitamins and some special vitamins required during pregnancy. Most of these vitamins are prescribed as regulated by U.S.…
